Liver regeneration – the best kept secret. A model of tissue injury response

Revista Espanola de Enfermedades Digestivas

Volumn 106, Issue 3, 2014, Pages 171-194

  Cienfuegos, Javier A ^a   Rotellar, Fernando ^a   Baixauli, Jorge ^a   Martínez Regueira, Fernando ^a   Pardo, Fernando ^a   Hernández Lizoáin, José Luis ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cell cycle; Hyperproliferative stress response; Induced pluripotentianl cells (iPS); Liver regeneration; P53; Sterile inflammatory response

Indexed keywords

EPIDERMAL GROWTH FACTOR; FARNESOID X RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN P53; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

APOPTOSIS; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HYPERPLASIA; LIVER REGENERATION; LIVER TRANSPLANTATION; MESENCHYMAL STEM CELL; NONHUMAN; PARTIAL HEPATECTOMY; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE NECROSIS; XENOBIOTIC METABOLISM; ANIMAL; HEPATITIS; LIVER DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CYTOKINES; HEPATITIS; HUMANS; LIVER DISEASES; LIVER REGENERATION;

EID: 84922008526     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (327)

1. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43:S45-53
2. Fausto N, Campbell J S. Liver regeneration. En: Arias IM, Alter HJ, Boyer JL, Cohen DE, Fausto N, Shafritz DA, et al, editores. The liver: biology and pathobiology. 5th ed. Oxford: Wiley & Sons; 2009. p. 549-65
3. Michalopoulos GK. Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol 2011;43:173-9
4. Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol 2013;3:485-513
5. Nevzorova YA, Trautwein C. Liver regeneration. En: Boyer TD, Wright TL, Manns MP, Zakim D, editores. Zakim and Boyer’s hepatology: A textbook of liver disease. 6th ed. Philadelphia: Saunders Elsevier; 2012. p. 20-35
6. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-47
7. Karp SJ. Clinical implications of advances in the basic science of liver repair and regeneration. Am J Transplant 2009;9:1973-80
8. Curado S, Stainier DY. deLiver’in regeneration: Injury response and development. Semin Liver Dis 2010;30:288-95
9. De Jonge J, Olthoff K M. Liver regeneration: Mechanisms and clinical relevance. In: Jarnagin WR, Belghiti J, Büchler MW, Chapman WC, D’Angelica MI, DeMatteo RP, et al, editors. Blumgart’s surgery of the liver, biliary tract, and pancreas. 5th ed. Philadelphia: Elsevier; 2012. p. 87-101
10. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-59
11. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777-85
12. Abdalla EK. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol 2010;102:960-7
13. Dutkowski P, De Rougemont O, Mullhaupt B, Clavien PA. Current and future trends in liver transplantation in Europe. Gastroenterology 2010;138:802,9.e1-4
14. Brown RS, Jr. Live donors in liver transplantation. Gastroenterology 2008;134:1802-13
15. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: The University of California, San Francisco, experience from 1993 to 2010. Arch Surg 2011;146:1052-9
16. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012;255:405-14
17. Lafuente S, Bertran MJ, Escorsell A. Artificial liver support. Literature review. Med Clin (Barc) 2011;136:484-7
18. Gupta S. Stem cells and hepatocyte transplantation. En: Boyer TD, Wright TL, Manns MP, Zakim D, editors. Zakim and Boyer’s hepatology: a textbook of liver disease. 6th ed. Philadelphia: Saunders Elsevier; 2012. p. 157-70
19. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence. Hepatology 2006;43:2-8
20. Dhawan A, Puppi J, Hughes RD, Mitry RR. Human hepatocyte transplantation: Current experience and future challenges. Nat Rev Gastroenterol Hepatol 2010;7:288-98
21. Shafritz DA, Oertel M, Dabeva M D, Grompe M. Liver repopulation by cell transplantation and the role of stem cells. En: Arias IM, Alter HJ, Boyer JL, Cohen DE, Fausto N, Shafritz DA, et al, editors. The liver: biology and pathobiology. 5th ed. Oxford: Wiley & Sons; 2009. p. 577-95
22. Esquilo. Prometeo encadenado. En: Esquilo, Sófocles, Eurípides, editores. Obras completas. Madrid: Cátedra; 2004. p. 85-126
23. Tiniakos DG, Kandilis A, Geller SA. Tityus: A forgotten myth of liver regeneration. J Hepatol 2010;53:357-61
24. Tillmanns H. Experimentelle und anatomische Untersuchungen über Wunden der Leber und Niere. Ein Beitrag zur Lehre von der antiseptischen Wundheilung. Arch Pathol Anat Physiol Klin Med 1879;78:437-74
25. Knolle P. Liver and immune system. En: Boyer TD, Wright TL, Manns MP, Zakim D, editors. Zakim and Boyer’s hepatology: A textbook of liver disease.6th ed. Philadelphia: Saunders Elsevier; 2012. p. 129-41
26. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009;27:147-63
27. Gillilland MG, Young V B, Huffnagle G B. Gastrointestinal microbial ecology with perspectives on health and disease. En: Johnson LR, Ghishan FK, Kaunitz JD, Merchant JL, Said HM, Wood JD, editors. Physiology of the gastrointestinal tract. Vol.1 5th ed. Amsterdam: Elsevier; 2012. p. 1119-34
28. Gonzalez-Navajas JM, Frances R, Such J. Bacterial DNA in patients with cirrhosis and sterile ascites. Its role as a marker of bacterial translocation and prognostic tool. Rev Esp Enferm Dig 2007;99:599-603
29. Jia C. Advances in the regulation of liver regeneration. Expert Rev Gastroenterol Hepatol 2011;5:105-21
30. Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26(Supl. 1):203-12
31. Pahlavan PS, Feldmann RE, Jr, Zavos C, Kountouras J. Prometheus’ challenge: Molecular, cellular and systemic aspects of liver regeneration. J Surg Res 2006;134:238-51
32. Morgan DO. The cell cycle. En: Morgan DO, editor. The cell cycle: Principles of control. London: New Science Press; 2007. p. 1-9
33. Satyanarayana A, Geffers R, Manns MP, Buer J, Rudolph KL. Gene expression profile at the G1/S transition of liver regeneration after partial hepatectomy in mice. Cell Cycle 2004;3:1405-17
34. Chauhan A, Lorenzen S, Herzel H, Bernard S. Regulation of mammalian cell cycle progression in the regenerating liver. J Theor Biol 2011;283:103-12
35. Duncan AW. Aneuploidy, polyploidy and ploidy reversal in the liver. Semin Cell Dev Biol 2013;24:347-56
36. Higgins GM, Anderson RM. Experimental pathology of the liver. 1. Restoration of the liver of the white rat following partial surgical removal, Arch Pathol 1931;12:186-8
37. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008;3:1167-70
38. Martins PN, Theruvath TP, Neuhaus P. Rodent models of partial hepatectomies. Liver Int 2008;28:3-11
39. Fausto N. Lessons from genetically engineered animal models. V. Knocking out genes to study liver regeneration: present and future. Am J Physiol 1999;277:G917-21
40. Mitchell C, Gilgenkrantz H. Transcriptional profiling of liver regeneration: New approaches to an old trick! J Hepatol 2003;38:847-9
41. Fukuhara Y, Hirasawa A, Li XK, Kawasaki M, Fujino M, Funeshima N, et al. Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatol 2003;38:784-92
42. Kurinna S, Barton MC. Hierarchies of transcriptional regulation during liver regeneration. Prog Mol Biol Transl Sci 2010;97:201-27
43. Locker J, Tian J, Carver R, Concas D, Cossu C, Ledda-Columbano GM, et al. A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology 2003;38:314-25
44. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol 2012;57:692-4
45. Call MK, Tsonis PA. Vertebrate limb regeneration. Adv Biochem Eng Biotechnol 2005;93:67-81
46. Matthews RP. Zebrafish as a model system for the study of liver development and disease. En: Arias IM, Alter HJ, Boyer JL, Cohen DE, Fausto, Shafritz DA, et al, editors. The liver: biology and pathobiology. 5th ed. Oxford: Wiley & Sons; 2009. p. 1067-74
47. Carlson BM. Some principles of regeneration in mammalian systems. Anat Rec B New Anat 2005;287:4-13
48. Morrison JI, Loof S, He P, Simon A. Salamander limb regeneration involves the activation of a multipotent skeletal muscle satellite cell population. J Cell Biol 2006;172:433-40
49. Otu HH, Naxerova K, Ho K, Can H, Nesbitt N, Libermann TA, et al. Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem 2007;282:11197-204
50. Mastellos D, Lambris J D. Integrating innate immunity into a global systems context: the complement paradigm shift. En: Rigoutsos I, Stephanopoulus G, editors. Systems Biology. Vol. 2. Networks, models, and applications. Oxford: Oxford University Press; 2007. p. 169-92
51. Chu J, Sadler KC. New school in liver development: Lessons from zebrafish. Hepatology 2009;50:1656-63
52. Miyaoka YF, Ebato KF, Kato HF, Arakawa SF, Shimizu SF, Miyajima A. Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol 2012;22:1166-75
53. Grisham JW. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res 1962;22:842-9
54. Rock KL, Lai JJ, Kono H. Innate and adaptive immune responses to cell death. Immunol Rev 2011;243:191-205
55. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol 2010;28:321-42
56. Barbalat R, Ewald SE, Mouchess ML, Barton GM. Nucleic acid recognition by the innate immune system. Annu Rev Immunol 2011;29:185-214
57. Lemasters JJ. Dying a thousand deaths: Redundant pathways from different organelles to apoptosis and necrosis. Gastroenterology 2005;129:351-60
58. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: A tale of two deaths? Hepatology 2006;43:S31-44
59. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012;143:1158-72
60. Mohammed FF, Khokha R. Thinking outside the cell: Proteases regulate hepatocyte division. Trends Cell Biol 2005;15:555-63
61. Bohm F, Kohler UA, Speicher T, Werner S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2010;2:294-305
62. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20
63. Medzhitov R. Inflammation 2010: New adventures of an old flame. Cell 2010;140:771-6
64. Calfee CS, Matthay MA. Clinical immunology: Culprits with evolutionary ties. Nature 2010;464:41-2
65. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 2009;361:1570-83
66. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 2005;41:857-67
67. Christophi C, Harun N, Fifis T. Liver regeneration and tumor stimulation -a review of cytokine and angiogenic factors. J Gastrointest Surg 2008;12:966-80
68. Malato Y, Naqvi S, Schurmann N, Ng R, Wang B, Zape J, et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 2011;121:4850-60
69. Morgan DO. The cell-cycle control system. En: Morgan DO, editor. The cell cycle: Principles of control. London: New Science Press; 2007. p. 27-55
70. Massague J. G1 cell-cycle control and cancer. Nature 2004;432:298-306
71. Michalopoulos GK. Liver regeneration after partial hepatectomy: Critical analysis of mechanistic dilemmas. Am J Pathol 2010;176:2-13
72. Kurinna S, Barton MC. Cascades of transcription regulation during liver regeneration. Int J Biochem Cell Biol 2011;43:189-97
73. Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Eng Biotechnol 2005;93:101-34
74. Duncan AW, Hickey RD, Paulk NK, Culberson AJ, Olson SB, Finegold MJ, et al. Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genet 2009;5:e1000385
75. Duncan AW, Hanlon Newell AE, Smith L, Wilson EM, Olson SB, Thayer MJ, et al. Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012;142:25-8
76. Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010;468:310-5
77. Maeno H, Ono T, Dhar DK, Sato T, Yamanoi A, Nagasue N. Expression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in rats. Liver Int 2005;25:1002-9
78. Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, Ito H, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001;34:683-9
79. Drixler TA, Vogten MJ, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE, et al. Liver regeneration is an angiogenesis-associated phenomenon. Ann Surg 2002;236:703,11; discussion 711-2
80. Drixler TA, Vogten JM, Gebbink MF, Carmeliet P, Voest EE, Borel Rinkes IH. Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy. Br J Surg 2003;90:1384-90
81. Vollmar B, Menger MD. The hepatic microcirculation: Mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 2009;89:1269-339
82. Wu Y, Guo F, Liu J, Xiao X, Huang L, He D. Triple labeling with three thymidine analogs reveals a well-orchestrated regulation of hepatocyte proliferation during liver regeneration. Hepatol Res 2011;41:1230-9
83. Ferri D, Moro L, Mastrodonato M, Capuano F, Marra E, Liquori GE, et al. Ultrastructural zonal heterogeneity of hepatocytes and mitochondria within the hepatic acinus during liver regeneration after partial hepatectomy. Biol Cell 2005;97:277-88
84. Petersen BE, Zajac VF, Michalopoulos GK. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 1998;27:1030-8
85. Dabeva MD, Shafritz DA. Hepatic stem cells and liver repopulation. Semin Liver Dis 2003;23:349-62
86. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin Liver Dis 2003;23:385-96
87. Van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009;71:241-60
88. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76
89. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007;2:3081-9
90. Cherry AB, Daley GQ. Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med 2013;64:277-90
91. Bhave VS, Paranjpe S, Bowen WC, Donthamsetty S, Bell AW, Khillan JS, et al. Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo. Hepatology 2011;54:1360-70
92. Liu T, Wang Y, Tai G, Zhang S. Could co-transplantation of iPS cells derived hepatocytes and MSCs cure end-stage liver disease? Cell Biol Int 2009;33:1180-3
93. Locke JE, Shamblott MJ, Cameron AM. Stem cells and the liver: Clinical applications in transplantation. Adv Surg 2009;43:35-51
94. Sancho-Bru P, Najimi M, Caruso M, Pauwelyn K, Cantz T, Forbes S, et al. Stem and progenitor cells for liver repopulation: Can we standardise the process from bench to bedside? Gut 2009;58:594-603
95. Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, Baharvand H. Induced pluripotent stem cells: A new era for hepatology. J Hepatol 2010;53:738-51
96. Diehl AM, Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin Invest 2013;123:1858-60
97. DeLeve LD. Liver sinusoidal endothelial cells and liver regeneration. J Clin Invest 2013;123:1861-6
98. Yu Y, Fisher JE, Lillegard JB, Rodysill B, Amiot B, Nyberg SL. Cell therapies for liver diseases. Liver Transpl 2012;18:9-21
99. Furst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: Initial experience. Radiology 2007;243:171-9
100. Mertsching H, Schanz J, Steger V, Schandar M, Schenk M, Hansmann J, et al. Generation and transplantation of an autologous vascularized bioartificial human tissue. Transplantation 2009;88:203-10
101. Orlando G, Wood KJ, Stratta RJ, Yoo JJ, Atala A, Soker S. Regenerative medicine and organ transplantation: Past, present, and future. Transplantation 2011;91:1310-7
102. Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008;322:1490-4
103. Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E, et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 2007;25:903-10
104. Overturf K, Al-Dhalimy M, Finegold M, Grompe M. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am J Pathol 1999;155:2135-43
105. Starzl TE, Fung J, Tzakis A, Todo S, Demetris AJ, Marino IR, et al. Baboon-to-human liver transplantation. Lancet 1993;341:65-71
106. Van Thiel DH, Gavaler JS, Kam I, Francavilla A, Polimeno L, Schade RR, et al. Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology 1987;93:1414-9
107. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002;8:233-40
108. Morgan DO. Control of cell proliferation and growth. In: Morgan DO, editor. The cell cycle: Principles of control. London: New Science Press; 2007. p. 195-225
109. Conlon I, Raff M. Size control in animal development. Cell 1999;96:235-44
110. Jorgensen P, Tyers M. How cells coordinate growth and division. Curr Biol 2004;14:R1014-27
111. Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB, et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010;467:707-10
112. Gupta S. Hepatic polyploidy and liver growth control. Semin Cancer Biol 2000;10:161-71
113. Lacroix B, Maddox AS. Cytokinesis, ploidy and aneuploidy. J Pathol 2012;226:338-51
114. Mitchison JM. Growth during the cell cycle. Int Rev Cytol 2003;226:165-258
115. Nurse P. Genetic control of cell size at cell division in yeast. Nature 1975;256:547-51
116. Gentric G, Celton-Morizur S, Desdouets C. Polyploidy and liver proliferation. Clin Res Hepatol Gastroenterol 2012;36:29-34
117. Kurinna S, Stratton SA, Coban Z, Schumacher JM, Grompe M, Duncan AW, et al. P53 Regulates a mitotic transcription program and determines ploidy in normal mouse liver. Hepatology 2013;57:2004-13
118. Minamishima YA, Nakayama K, Nakayama K. Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2- deficient mice. Cancer Res 2002;62:995-9
119. Wirth KG, Wutz G, Kudo NR, Desdouets C, Zetterberg A, Taghybeeglu S, et al. Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. J Cell Biol 2006;172:847-60
120. Edgar BA, Orr-Weaver TL. Endoreplication cell cycles: More for less. Cell 2001;105:297-306
121. Lu P, Prost S, Caldwell H, Tugwood JD, Betton GR, Harrison DJ. Microarray analysis of gene expression of mouse hepatocytes of different ploidy. Mamm Genome 2007;18:617-26
122. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009;460:278-82
123. Kamel IR, Erbay N, Warmbrand G, Kruskal JB, Pomfret EA, Raptopoulos V. Liver regeneration after living adult right lobe transplantation. Abdom Imaging 2003;28:53-7
124. Jin MB, Shimamura T, Taniguchi M, Nagasako Y, Suzuki T, Kamiyama T, et al. Liver regeneration in living-donor liver transplantation. Nihon Geka Gakkai Zasshi 2004;105:674-9
125. Humar A, Kosari K, Sielaff TD, Glessing B, Gomes M, Dietz C, et al. Liver regeneration after adult living donor and deceased donor splitliver transplants. Liver Transpl 2004;10:374-8
126. Mortensen KE, Conley LN, Hedegaard J, Kalstad T, Sorensen P, Bendixen C, et al. Regenerative response in the pig liver remnant varies with the degree of resection and rise in portal pressure. Am J Physiol Gastrointest Liver Physiol 2008;294:G819-30
127. Bucher NL, Swaffield MN. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res 1964;24:1611-25
128. Weinbren K, Tarsh E. The mitotic response in the rat liver after different regenerative stimuli. Br J Exp Pathol 1964;45:475-80
129. Andersson U, Tracey KJ. Reflex principles of immunological homeostasis. Annu Rev Immunol 2012;30:313-35
130. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000;127:117-26
131. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003;198:913-23
132. DeAngelis RA, Markiewski MM, Lambris JD. Liver regeneration: A link to inflammation through complement. Adv Exp Med Biol 2006;586:17-34
133. Whitacre JM. Biological robustness: Paradigms, mechanisms, and systems principles. Front Genet 2012;3:67
134. Stelling J, Sauer U, Szallasi Z, Doyle FJ, 3rd, Doyle J. Robustness of cellular functions. Cell 2004;118:675-85
135. Kitano H. Cancer as a robust system: Implications for anticancer therapy. Nat Rev Cancer 2004;4:227-35
136. Corlu A, Loyer P. Regulation of the g1/s transition in hepatocytes: Involvement of the cyclin-dependent kinase cdk1 in the DNA replication. Int J Hepatol 2012;2012:689324
137. Tyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: Dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 2003;15:221-31
138. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997;13:261-91
139. Albrecht JH, Mullany L K. Cell cycle control in the liver. En: Arias IM, Alter HJ, Boyer JL, Cohen DE, Fausto N, Shafritz DA, et al, editors. The liver: Biology and pathobiology. 5th ed. Oxford: Wiley & Sons; 2009. p. 1015-27
140. Pardee AB. G1 events and regulation of cell proliferation. Science 1989;246:603-8
141. Nurse P. Wee beasties. Nature 2004;432:557
142. Murray AW. Recycling the cell cycle: Cyclins revisited. Cell 2004;116:221-34
143. Stefater JA, 3rd, Ren S, Lang RA, Duffield JS. Metchnikoff’s policemen: Macrophages in development, homeostasis and regeneration. Trends Mol Med 2011;17:743-52
144. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134:1641-54
145. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: A clear and present danger. Physiol Rev 2010;90:1165-94
146. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009;16:3-11
147. Guicciardi ME, Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis 2010;30:402-10
148. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8:279-89
149. Strey CW, Siegmund B, Rosenblum S, Marquez-Pinilla RM, Oppermann E, Huber-Lang M, et al. Complement and neutrophil function changes after liver resection in humans. World J Surg 2009;33:2635-43
150. Solis-Munoz P. Acute on chronic liver failure and prognostic factors: Time for reevaluation. Rev Esp Enferm Dig 2011;103:169-76
151. Helling TS. Liver failure following partial hepatectomy. HPB (Oxford) 2006;8:165-74
152. Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. Br J Surg 2011;98:1188-200
153. Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 2008;49:845-61
154. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghoner A, Vidacek D, Siewert E, et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 2005;42:195-201
155. Van Golen RF, Van Gulik TM, Heger M. The sterile immune response during hepatic ischemia/reperfusion. Cytokine Growth Factor Rev 2012;23:69-84
156. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045
157. Matzinger P. An innate sense of danger. Semin Immunol 1998;10:399-415
158. Matzinger P. The danger model: A renewed sense of self. Science 2002;296:301-5
159. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006;26:430-7
160. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886-900
161. Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 2007;81:1-5
162. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511
163. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;3:56
164. Lamkanfi M, Dixit VM. Inflammasomes: Guardians of cytosolic sanctity. Immunol Rev 2009;227:95-105
165. Leemans JC, Cassel SL, Sutterwala FS. Sensing damage by the NLRP3 inflammasome. Immunol Rev 2011;243:152-62
166. Trauner M, Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011;140:1120-1125.e1-12
167. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012;335:936-41
168. Basta G, Navarra T, De Simone P, Del Turco S, Gastaldelli A, Filipponi F. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? Liver Transpl 2011;17:633-40
169. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825-30
170. DeAngelis RA, Markiewski MM, Kourtzelis I, Rafail S, Syriga M, Sandor A, et al. A complement-IL-4 regulatory circuit controls liver regeneration. J Immunol 2012;188:641-8
171. Kohl J. The role of complement in danger sensing and transmission. Immunol Res 2006;34:157-76
172. Markiewski MM, DeAngelis RA, Strey CW, Foukas PG, Gerard C, Gerard N, et al. The regulation of liver cell survival by complement. J Immunol 2009;182:5412-8
173. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007;171:715-27
174. Leslie M. Immunology. The new view of complement. Science 2012;337:1034-7
175. Matzinger P, Kamala T. Tissue-based class control: The other side of tolerance. Nat Rev Immunol 2011;11:221-30
176. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010;10:131-44
177. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 2005;41:443-50
178. Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: Crosstalk between the liver and gut. J Physiol 2012;590:447-58
179. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 2008;48:322-35
180. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006;312:233-6
181. Cornell RP, Liljequist BL, Bartizal KF. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide- resistant mice. Hepatology 1990;11:916-22
182. Cornell RP. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration. Am J Physiol 1985;249:R563-9
183. Cornell RP. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol 1985;249:R551-62
184. Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 1997;26:896-904
185. Arthur MJ. Matrix degradation in liver: A role in injury and repair. Hepatology 1997;26:1069-71
186. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000;174:160-71
187. Van Sweringen HL, Sakai N, Tevar AD, Burns JM, Edwards MJ, Lentsch AB. CXC chemokine signaling in the liver: Impact on repair and regeneration. Hepatology 2011;54:1445-53
188. Hancock JT. Extracellular signals: hormones, cytokines and growth factors. En: Hancock JT, editor. Cell signalling. 3rd ed. Oxford: Oxford University Press; 2010. p. 55-77
189. Morello D, Fitzgerald MJ, Babinet C, Fausto N. c-myc, c-fos, and c-jun regulation in the regenerating livers of normal and H-2K/c-myc transgenic mice. Mol Cell Biol 1990;10:3185-93
190. Steer CJ. Liver regeneration. FASEB J 1995;9:1396-400
191. Li JW, Wang GP, Fan JY, Chang CF, Xu CS. Eight paths of ERK1/2 signalling pathway regulating hepatocyte proliferation in rat liver regeneration. J Genet 2011;90:435-42
192. Terui K, Ozaki M. The role of STAT3 in liver regeneration. Drugs Today (Barc) 2005;41:461-9
193. Selzner N, Selzner M, Odermatt B, Tian Y, Van Rooijen N, Clavien PA. ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 2003;124:692-700
194. Levy DE, Lee CK. What does Stat3 do? J Clin Invest 2002;109:1143-8
195. Li W, Liang X, Kellendonk C, Poli V, Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002;277:28411-7
196. Malato Y, Sander LE, Liedtke C, Al-Masaoudi M, Tacke F, Trautwein C, et al. Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration. Hepatology 2008;47:2036-50
197. Borowiak M, Garratt AN, Wustefeld T, Strehle M, Trautwein C, Birchmeier C. Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A 2004;101:10608-13
198. Taub R, Greenbaum LE, Peng Y. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration. Semin Liver Dis 1999;19:117-27
199. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, Lambris JD. A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 2001;166:2479-86
200. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet Toll-like receptor expression modulates lipopolysaccharideinduced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006;107:637-41
201. Semple JW, Italiano JE,Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11:264-74
202. Nowatari T, Fukunaga K, Ohkohchi N. Regulation of signal transduction and role of platelets in liver regeneration. Int J Hepatol 2012;2012:542479
203. Nurden AT. Platelets and tissue remodeling: Extending the role of the blood clotting system. Endocrinology 2007;148:3053-5
204. Tomiyama K, Miyazaki M, Nukui M, Takaishi M, Nakao A, Shimizu N, et al. Limited contribution of cells of intact extrahepatic tissue origin to hepatocyte regeneration in transplanted rat liver. Transplantation 2007;83:624-30
205. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg 2010;251:300-6
206. Lisman T, Porte RJ. The role of platelets in liver inflammation and regeneration. Semin Thromb Hemost 2010;36:170-4
207. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet- derived serotonin mediates liver regeneration. Science 2006;312:104-7
208. Tian Y, Graf R, El-Badry AM, Lesurtel M, Furrer K, Moritz W, et al. Activation of serotonin receptor-2B rescues small-for-size liver graft failure in mice. Hepatology 2011;53:253-62
209. Matondo RB, Punt C, Homberg J, Toussaint MJ, Kisjes R, Korporaal SJ, et al. Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am J Physiol Gastrointest Liver Physiol 2009;296:G963-8
210. Moolten FL, Bucher NL. Regeneration of rat liver: Transfer of humoral agent by cross circulation. Science 1967;158:272-4
211. Michalopoulos G, Cianciulli HD, Novotny AR, Kligerman AD, Strom SC, Jirtle RL. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res 1982;42:4673-82
212. Jirtle RL, Michalopoulos G. Effects of partial hepatectomy on transplanted hepatocytes. Cancer Res 1982;42:3000-4
213. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 2002;277:29355-8
214. Glotzbach JP, Wong VW, Gurtner GC, Longaker MT. Regenerative medicine. Curr Probl Surg 2011;48:148-212
215. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A 1995;92:1142-6
216. Bustos M, Beraza N, Lasarte JJ, Baixeras E, Alzuguren P, Bordet T, et al. Protection against liver damage by cardiotrophin-1: A hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 2003;125:192-201
217. Bode JG, Heinrich P C. Interleukin-6 signaling during the acute-phase response of the liver. En: Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz DA, editors. The liver biology and pathobiology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 565-80
218. Szabo G, Romics L, Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002;6:1045,66, x.
219. Streetz KL, Wustefeld T, Klein C, Manns MP, Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) 2001;47:661-73
220. Trautwein C, Boker K, Manns MP. Hepatocyte and immune system: Acute phase reaction as a contribution to early defence mechanisms. Gut 1994;35:1163-6
221. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 2008;214:161-78
222. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-62
223. Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, et al. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994;263:89-92
224. Matsuda T, Hirano T. Association of p72 tyrosine kinase with Stat factors and its activation by interleukin-3, interleukin-6, and granulocyte colony-stimulating factor. Blood 1994;83:3457-61
225. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-83
226. Jin X, Zhang Z, Beer-Stolz D, Zimmers TA, Koniaris LG. Interleukin- 6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 2007;46:802-12
227. Iniguez M, Berasain C, Martinez-Anso E, Bustos M, Fortes P, Pennica D, et al. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med 2006;203:2809-15
228. Oyama T, Sadamori H, Matsukawa H, Murata H, Umeda Y, Watanabe Y, et al. Small liver graft regenerates through immediate increase of HGF and IL-6--possible involvement of sinusoidal tensile/shear stress in small liver graft. Hepatogastroenterology 2007;54:2078-83
229. Blindenbacher A, Wang X, Langer I, Savino R, Terracciano L, Heim MH. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 2003;38:674-82
230. Beraza N, Marques JM, Martinez-Anso E, Iniguez M, Prieto J, Bustos M. Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration. Hepatology 2005;41:460-9
231. Tunon MJ, San Miguel B, Crespo I, Riezu-Boj JI, Larrea E, Alvarez M, et al. Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin. J Virol 2011;85:13124-32
232. Marques JM, Belza I, Holtmann B, Pennica D, Prieto J, Bustos M. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 2007;45:639-48
233. White P, Brestelli JE, Kaestner KH, Greenbaum LE. Identification of transcriptional networks during liver regeneration. J Biol Chem 2005;280:3715-22
234. Rodrigues CMP, Castro RE, Steer CJ. The role of bile acids in the modulation of apoptosis. Principles of Medical Biology 2004;15:119-45
235. Hulzebos CV, Renfurm L, Bandsma RH, Verkade HJ, Boer T, Boverhof R, et al. Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: Application to rodents and humans. J Lipid Res 2001;42:1923-9
236. Palmeira CM, Rolo AP. Mitochondrially-mediated toxicity of bile acids. Toxicology 2004;203:1-15
237. Monte MJ, Martinez-Diez MC, El-Mir MY, Mendoza ME, Bravo P, Bachs O, et al. Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration. J Hepatol 2002;36:534-42
238. Gravante G, Knowles T, Ong SL, Al-Taan O, Metcalfe M, Dennison AR, et al. Bile changes after liver surgery: Experimental and clinical lessons for future applications. Dig Surg 2010;27:450-60
239. Chiang JY. Regulation of bile acid synthesis: Pathways, nuclear receptors, and mechanisms. J Hepatol 2004;40:539-51
240. Martinez JD, Stratagoules ED, LaRue JM, Powell AA, Gause PR, Craven MT, et al. Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 1998;31:111-8
241. Fernandez-Barrena MG, Monte MJ, Latasa MU, Uriarte I, Vicente E, Chang HC, et al. Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. J Hepatol 2012;56:367-73
242. Chen WD, Wang YD, Zhang L, Shiah S, Wang M, Yang F, et al. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 2010;51:953-62
243. Weymann A, Hartman E, Gazit V, Wang C, Glauber M, Turmelle Y, et al. P21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 2009;50:207-15
244. Fisette A, Hassanain M, Metrakos P, Doi SA, Salman A, Schricker T, et al. High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. J Clin Endocrinol Metab 2012;97:217-26
245. Hassanain M, Metrakos P, Fisette A, Doi SA, Schricker T, Lattermann R, et al. Randomized clinical trial of the impact of insulin therapy on liver function in patients undergoing major liver resection. Br J Surg 2013;100:610-8
246. Costa RH, Kalinichenko VV, Holterman AX, Wang X. Transcription factors in liver development, differentiation, and regeneration. Hepatology 2003;38:1331-47
247. Wang X, Krupczak-Hollis K, Tan Y, Dennewitz MB, Adami GR, Costa RH. Increased hepatic Forkhead Box M1B (FoxM1B) levels in old-aged mice stimulated liver regeneration through diminished p27Kip1 protein levels and increased Cdc25B expression. J Biol Chem 2002;277:44310-6
248. Brezillon N, Lambert-Blot M, Morosan S, Couton D, Mitchell C, Kremsdorf D, et al. Transplanted hepatocytes over-expressing Fox- M1B efficiently repopulate chronically injured mouse liver independent of donor age. Mol Ther 2007;15:1710-5
249. Marchioro TL, Porter KA, Brown BI, Otte JB, Starzl TE. The effect of partial portacaval transposition on the canine liver. Surgery 1967;61:723-32
250. Starzl TE, Porter KA, Francavilla A. The Eck fistula in animals and humans. Curr Probl Surg 1983;20:687-752
251. Starzl TE, Porter KA, Francavilla JA, Benichou J, Putnam CW. A hundred years of the hepatotrophic controversy. Ciba Found Symp 1977;(55):111-29
252. Francavilla A, Starzl TE, Porter K, Foglieni CS, Michalopoulos GK, Carrieri G, et al. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck’s fistula. Hepatology 1991;14:665-70
253. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;81:414-9
254. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-3
255. Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol 2011;26 Suppl 1:188-202
256. Michalopoulos G, Houck KA, Dolan ML, Leutteke NC. Control of hepatocyte replication by two serum factors. Cancer Res 1984;44:4414-9
257. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990;173:42-7
258. Schirmacher P, Geerts A, Pietrangelo A, Dienes HP, Rogler CE. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992;15:5-11
259. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 1996;132:1133-49
260. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A 1991;88:415-9
261. Hernandez J, Zarnegar R, Michalopoulos GK. Characterization of the effects of human placental HGF on rat hepatocytes. J Cell Physiol 1992;150:116-21
262. Mars WM, Liu ML, Kitson RP, Goldfarb RH, Gabauer MK, Michalopoulos GK. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 1995;21:1695-701
263. Hamanoue M, Kawaida K, Takao S, Shimazu H, Noji S, Matsumoto K, et al. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 1992;16:1485-92
264. Matsumoto K, Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996;119:591-600
265. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-44
266. Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 2007;213:316-25
267. Comoglio PM. Pathway specificity for Met signalling. Nat Cell Biol 2001;3:E161-2
268. Stolz DB, Mars WM, Petersen BE, Kim TH, Michalopoulos GK. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res 1999;59:3954-60
269. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991;13:743-50
270. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699-702
271. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A 2004;101:4477-82
272. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25
273. Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995;269:234-8
274. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci U S A 2007;104:17081-6
275. Kiso S, Kawata S, Tamura S, Inui Y, Yoshida Y, Sawai Y, et al. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 2003;124:701-7
276. Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, et al. Amphiregulin: An early trigger of liver regeneration in mice. Gastroenterology 2005;128:424-32
277. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1. J Biol Chem 1996;271:11484-92
278. Loyer P, Corlu A, Desdouets C. Regulation of the hepatocyte cell cycle: Signaling pathways and protein kinases. Int J Hepatol 2012;2012:592354
279. Russell WE, Kaufmann WK, Sitaric S, Luetteke NC, Lee DC. Liver regeneration and hepatocarcinogenesis in transforming growth factoralpha- targeted mice. Mol Carcinog 1996;15:183-9
280. Webber EM, Wu JC, Wang L, Merlino G, Fausto N. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994;145:398-408
281. Russell WE, Dempsey PJ, Sitaric S, Peck AJ, Coffey RJ, Jr. Transforming growth factor-alpha (TGF alpha) concentrations increase in regenerating rat liver: Evidence for a delayed accumulation of mature TGF alpha. Endocrinology 1993;133:1731-8
282. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, et al. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 2001;107:1285-92
283. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700
284. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009;136:3699-714
285. Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 2007;101:9-33
286. Chari RS, Price DT, Sue SR, Meyers WC, Jirtle RL. Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am J Surg 1995;169:126,31; discussion 131-2
287. Macias-Silva M, Li W, Leu JI, Crissey MA, Taub R. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J Biol Chem 2002;277:28483-90
288. Nishikawa Y, Wang M, Carr BI. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition. J Cell Physiol 1998;176:612-23
289. Russell WE, Coffey RJ, Jr, Ouellette AJ, Moses HL. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988;85:5126-30
290. Bouzahzah B, Fu M, Iavarone A, Factor VM, Thorgeirsson SS, Pestell RG. Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivo. Cancer Res 2000;60:4531-7
291. Oe S, Lemmer ER, Conner EA, Factor VM, Leveen P, Larsson J, et al. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 2004;40:1098-105
292. Kogure K, Zhang YQ, Maeshima A, Suzuki K, Kuwano H, Kojima I. The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver. Hepatology 2000;31:916-21
293. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010;16:814-20
294. Uygun BE, Yarmush ML, Uygun K. Application of whole-organ tissue engineering in hepatology. Nat Rev Gastroenterol Hepatol 2012;9:738-44
295. Soto-Gutierrez A, Wertheim JA, Ott HC, Gilbert TW. Perspectives on whole-organ assembly: Moving toward transplantation on demand. J Clin Invest 2012;122:3817-23
296. Hammond JS, Gilbert TW, Howard D, Zaitoun A, Michalopoulos G, Shakesheff KM, et al. Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol 2011;54:279-87
297. Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011;13:27-53
298. Baptista PM, Siddiqui MM, Lozier G, Rodriguez SR, Atala A, Soker S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011;53:604-17
299. Gkretsi V, Bowen WC, Yang Y, Wu C, Michalopoulos GK. Integrinlinked kinase is involved in matrix-induced hepatocyte differentiation. Biochem Biophys Res Commun 2007;353:638-43
300. Gkretsi V, Apte U, Mars WM, Bowen WC, Luo JH, Yang Y, et al. Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology 2008;48:1932-41
301. Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S, et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 2009;50:844-51
302. Shafiei MS, Rockey DC. The role of integrin-linked kinase in liver wound healing. J Biol Chem 2006;281:24863-72
303. Song JJ, Guyette JP, Gilpin SE, Gonzalez G, Vacanti JP, Ott HC. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013;19:646-51
304. Song JJ, Kim SS, Liu Z, Madsen JC, Mathisen DJ, Vacanti JP, et al. Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg 2011;92:998,1005; discussion 1005-6
305. Bakkenist CJ, Kastan MB. Initiating cellular stress responses. Cell 2004;118:9-17
306. Ben-Porath I, Weinberg RA. When cells get stressed: An integrative view of cellular senescence. J Clin Invest 2004;113:8-13
307. Morgan DO. The DNA damage response. In: Morgan DO, editor. The cell cycle: Principles of control. London: New Science Press; 2007. p. 227-45
308. Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005;120:513-22
309. Weinberg RA. P53 and apoptosis: master guardian and executioner. In: Weinberg RA, editor. The biology of cancer. New York: Garland Science; 2007. p. 307-56
310. Vousden KH, Lu X. Live or let die: the cell’s response to p53. Nat Rev Cancer 2002;2:594-604
311. Levine AJ. P53, the Cellular Gatekeeper for Growth and Division. Cell 1997;88:323-31
312. Efeyan A, Serrano M. P53: Guardian of the genome and policeman of the oncogenes. Cell Cycle 2007;6:1006-10
313. Li CC, Chu HY, Yang CW, Chou CK, Tsai TF. Aurora-A overexpression in mouse liver causes p53-dependent premitotic arrest during liver regeneration. Mol Cancer Res 2009;7:678-88
314. Maddocks OD, Vousden KH. Metabolic regulation by p53. J Mol Med (Berl) 2011;89:237-45
315. Fededa JP, Gerlich DW. Molecular control of animal cell cytokinesis. Nat Cell Biol 2012;14:440-7
316. Gallagher SJ, Kefford RF, Rizos H. The ARF tumour suppressor. Int J Biochem Cell Biol 2006;38:1637-41
317. Wadhwa R, Sugihara T, Taira K, Kaul SC. The ARF-p53 senescence pathway in mouse and human cells. Histol Histopathol 2004;19:311-6
318. Zhou J, Schmid T, Schnitzer S, Brune B. Tumor hypoxia and cancer progression. Cancer Lett 2006;237:10-21
319. Demetris AJ, Seaberg EC, Wennerberg A, Ionellie J, Michalopoulos G. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996;149:439-48
320. Stravitz RT, Kramer D J. Acute liver failure. En: Boyer TD, Manns MP, Sanyal AJ, editores. Zakim and Boyer’s hepatology: a textbook of liver disease. 6th ed. Philadelphia: Saunders Elsevier; 2012. p. 327-51
321. Oda M, Yokomori H, Han JY. Regulatory mechanisms of hepatic microcirculatory hemodynamics: hepatic arterial system. Clin Hemorheol Microcirc 2006;34:11-26
322. Ninomiya M, Shirabe K, Terashi T, Ijichi H, Yonemura Y, Harada N, et al. Deceleration of regenerative response improves the outcome of rat with massive hepatectomy. Am J Transplant 2010;10: 1580-7
323. Markiewski MM, DeAngelis RA, Lambris JD. Liver inflammation and regeneration: Two distinct biological phenomena or parallel pathophysiologic processes? Mol Immunol 2006;43:45-56
324. Clavien PA, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher A, El-Badry AM. What is critical for liver surgery and partial liver transplantation: Size or quality? Hepatology 2010;52:715-29
325. Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 2013;499:481-4
326. Ordonez MP, Goldstein LS. Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver. Semin Liver Dis 2012;32:298-306
327. Beginner’s Traps. In: Ramón y Cajal S, editor. Advice for a young investigator. Cambridge, Massachussetts: Massachussetts Institute of Technology; 1999. p. 9-27.